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Abstract
The number of patients with Alzheimer’s disease (AD) is increasing and so is the number of
patients driving a car. To enable patients to retain their mobility while at the same time not
endangering public safety, each patient should be assessed for fitness to drive. The aim of
this study is to develop a method to assess fitness to drive in a clinical setting, using three
types of assessments, i.e. clinical interviews, neuropsychological assessment and driving
simulator rides. The goals are (1) to determine for each type of assessment which combina-
tion of measures is most predictive for on-road driving performance, (2) to compare the pre-
dictive value of clinical interviews, neuropsychological assessment and driving simulator
evaluation and (3) to determine which combination of these assessments provides the best
prediction of fitness to drive. Eighty-one patients with AD and 45 healthy individuals partici-
pated. All participated in a clinical interview, and were administered a neuropsychological
test battery and a driving simulator ride (predictors). The criterion fitness to drive was deter-
mined in an on-road driving assessment by experts of the CBR Dutch driving test organisa-
tion according to their official protocol. The validity of the predictors to determine fitness to
drive was explored by means of logistic regression analyses, discriminant function analy-
ses, as well as receiver operating curve analyses. We found that all three types of assess-
ments are predictive of on-road driving performance. Neuropsychological assessment had
the highest classification accuracy followed by driving simulator rides and clinical inter-
views. However, combining all three types of assessments yielded the best prediction for
fitness to drive in patients with AD with an overall accuracy of 92.7%, which makes this
method highly valid for assessing fitness to drive in AD. This method may be used to advise
patients with AD and their family members about fitness to drive.
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Introduction
Alzheimer’s disease (AD) is the most common aetiology of dementia and the number of
patients with dementia is increasing rapidly [1,2]. AD is a progressive disease in which multiple
cognitive domains are affected. In addition to the memory domain, also the domains of atten-
tion, visuospatial abilities, executive functioning, language and praxis are frequently impaired
[3,4]. Impairments in these cognitive domains may influence many aspects of daily living, in
particular the execution of complex tasks may be affected, such as driving a car [5].
Driving is a very meaningful instrumental activity of daily living and the preferred mode of
transport of older adults [6]. Nevertheless, disabilities of old age could lead to an inability to
drive a car safely. Driving cessation creates particular logistical problems for households of
patients with AD [7]. While older drivers with other disabilities (e.g. cardiovascular diseases,
muscular-skeletal conditions, visual impairment) may change to other modes of transport such
as public transport by themselves, patients with AD typically need a responsible caregiver to
travel with them [7], as many patients with AD experience a lack of orientation in public trans-
port stations. Getting used to new transportation means (e.g. public transport) is cognitively
more demanding in comparison to maintaining routine travel means (i.e. driving). Conse-
quently, a large proportion of patients with AD depend on car driving to maintain independent
mobility and autonomy [5,7]. There is a strong interest in maintaining mobility for patients
with AD. However, safety risks for both the individual with AD as well as other road users have
to be considered as well.
Previous research has shown that AD may impair driving [8–11]. A driver with AD might
fail to recall road regulations and routes [12], may fail to oversee the infrastructure and per-
ceive the distance to other vehicles, or may respond too slowly to the environment resulting in
strategic and tactical errors, especially in non-automated situations [13]. Patients with AD are
expected to become unable to drive safely in course of the disease and hence it is generally rec-
ommended that patients with severe AD (Clinical Dementia Rating (CDR)> 1) cease driving
[14–17]. However, not all patients with AD are unsafe to drive [9–11]. Currently, AD is more
frequently diagnosed in an earlier stage of the disease. Especially these patients with AD may
be able to continue driving safely for several years after the diagnosis [14]. These findings indi-
cate that it is necessary to investigate fitness to drive (FTDr) of patients with AD on a patient
by patient basis.
On-road assessments are commonly used to investigate FTDr in many countries [18,19]. In
an on-road assessment, an FTDr expert (e.g. from a driver’s licence authority) drives with a
patient and judges whether the patient is driving safely. Considering the high and growing
number of patients with AD, it becomes increasingly difficult to assess all patients with AD on
the road soon after they have been diagnosed [20]. Other ways to evaluate FTDr are clinical
interviews [21,22], neuropsychological assessments [14,23] and driving simulator rides [18,24].
Clinical interviews with both the patient with AD and a family member are regularly per-
formed and certainly provide important information at clinical evaluation, since they may pro-
vide knowledge about previous accidents, near misses, fines, or changes in driving behaviour
[21]. Nevertheless, one has to be cautious, because caregiver reports do not necessarily predict
on-road driving performance [25]. AD has a relatively slow progression, therefore changes in
driving performance may also be slow and difficult to detect for family members. In addition,
family members who rely on the driver with AD for transportation may give biased reports
[21].
Neuropsychological assessments are also frequently used for the evaluation of FTDr and
include tests that assess cognitive functions known to be impaired in many patients with AD
and that may affect driving. Performance on many neuropsychological tests has moderately
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high correlations with on-road performance, particularly tests of attention and visuospatial
functioning [14,23]. Clinicians may use the results of these tests to help predict whether a
patient with AD is driving safely [14], however, the accuracy of these predictions is often
regarded as being too low [26,27]. Kay and colleagues (2012)[19] have suggested to aim for
both sensitivity and specificity of at least 90%. Using a single test, such as clock drawing or the
Trail Making Test, is probably not sufficient to reach this goal [28,29]. Combinations of tests
may be more likely to predict FTDr than any single test [30], but even with multiple tests it is
very difficult to achieve both high sensitivity and specificity for a binary classification of FTDr
[26].
Driving simulators can mimic real-world driving in a controlled environment. Driving sim-
ulator rides can be seen as complex neuropsychological tasks. However, here the simulator out-
come is categorized separately from neuropsychological assessments, because (1) the driving
simulator used was not developed as a clinical tool to assess cognitive functions, but is an
experimental tool for traffic research to measure driving behaviour, and (2) the technical and
administrative set up of driving simulators and neuropsychological tests are different. Freund
et al. (2002)[18] have shown that simulated driving correlates significantly with on-road driv-
ing in older adults, with and without cognitive impairments. Consequently, driving simulator
rides may represent another method to predict on-road driving performance. However, it is
not yet determined whether actual prospective accidents can be predicted with simulated driv-
ing [31]. Moreover, a large percentage of older drivers may not tolerate simulated driving due
to motion sickness [32,33].
Using methods other than on-road assessments might have advantages. A routine clinical
evaluation usually begins with a clinical interview using self- and informant reports. If cogni-
tive impairments are reported during the interview, a neuropsychological assessment is fre-
quently initiated. Consequently, clinical interviews and neuropsychological assessments
represent cost-effective approaches which may be useful in the prediction of FTDr. Driving
simulator rides are not part of standard clinical evaluations, but driving simulators are increas-
ingly available in clinical units and research centres and driving simulator rides are safer and
easier to conduct than on-road assessments. Currently, there is no standardised procedure to
use these methods to evaluate FTDr. It is vital to determine the usefulness of these alternative
methods in combination with one another.
The current study aims to develop a method to investigate FTDr in patients with AD in a
clinical setting. The study includes three types of assessments for the prediction of on-road
driving performance, i.e. clinical interviews, neuropsychological assessments and driving simu-
lator rides. In addition, all participants were evaluated using an on-road assessment (criterion).
The goals of the study are threefold. The first goal is to determine for each of the three types of
assessments separately which combination of measures are most predictive for on-road driving
performance. Second, the predictive value of the clinical interviews, neuropsychological assess-
ment and driving simulator rides are compared with one another to determine which type of
assessment is most useful for the prediction of FTDr. Third, the predictive accuracy of FTDr is
determined when using the best possible combination of clinical interviews, neuropsychologi-
cal assessment and/or driving simulator rides.
Materials and Methods
Participants
Patients with Alzheimer’s disease. Participants with AD (n = 81) were assessed at five
locations in the Netherlands; at two hospitals, two nursing homes and a university, in 2013 and
2014. Inclusion criteria for patients were an age above 30, a diagnosis of AD and a wish to
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continue driving. AD was diagnosed by a neurologist, geriatrician, psychiatrist or general prac-
titioner. All participants held a current valid driver’s licence. Exclusion criteria were the diag-
nosis of other neurological or psychiatric conditions that may influence driving performance
and usage of medications with a severe influence on driving ability.
Of the 81 patients with AD, 71 participants (87.7%) met criteria for probable AD and 10
participants (12.3%) met criteria for both probable AD and vascular dementia (mixed demen-
tia) [34,35]. Patients were aged 52 to 91 years (mean = 72.3 years; SD = 9.4 years) and 53
(65.4%) of the patients were men. Patients had held a driver’s licence for 25 to 73 years
(mean = 49.8; SD = 9.5 years) and the estimation of their total distance driven ranges from
107,000 to 15,230,000 km (mean = 1,426,000; SD = 2,867,000 km).
Healthy participants. Furthermore, 45 healthy individuals participated in the study.
Inclusion criteria for healthy participants were an age above 70, no diagnoses of psychiatric or
neurological conditions, no diagnoses that would require referral to the Dutch driving test
organisation, no usage of medications with a severe influence on driving ability and a wish to
continue driving. The age limit for healthy participants was higher than for patients to avoid
having a healthy sample that is younger than the patient sample. All healthy participants
also held a current valid driver’s licence. Healthy participants were aged 70 to 87 years
(mean = 76.3; SD = 4.7 years) and 24 (53.3%) healthy participants were men. Healthy partici-
pants had held a driver’s licence for 7 to 63 years (mean = 51.1; SD = 8.6 years) and the estima-
tion of their total distance driven ranges from 22,000 to 7,213,000 km (mean = 1,258,000;
SD = 1,435,000 km).
Table 1 presents characteristics of patients with AD and healthy participants. As expected, a
higher proportion of patients with AD had a CDR-score of 0.5 or 1 compared to healthy partic-
ipants (χ2 = 112.5; df = 2; p< .001). Correspondingly, patients with AD had a lower score on
the Mini Mental State Examination (MMSE) (U = 131.0; p< .001; r = 0.771) than healthy
participants. Other characteristics did not differ significantly between patients with AD and
healthy participants.
Measures
The subsequent description of the methods comprises only tests and measures which were con-
sidered in the present study. The preselection of measures was based on the literature and
intended to cover relevant cognitive domains (e.g. attention, executive functioning and visuo-
spatial functions), with no redundancy [21,36–39]. For a full description of the study protocol,
please see S1 Appendix.
Clinical interviews and ratings. Clinical interviews and ratings consisted of the CDR and
a driving questionnaire, and involved both the participant and an informant (e.g. the partici-
pant’s partner).
Participants were requested to complete a driving questionnaire (adapted from the Safe
Driving Behaviour Measure [37]). The questionnaire consists of three parts: a demographical
profile (7 items), a driving profile (23 items) and safe driving behaviour queries (54 items). For
this study, one item of the driving profile was used, i.e. the kilometres driven in the previous
twelve months representing recent driving experience. The question was categorical with the
following answer options: less than 1.000 km (1), 1.000–5.000 km (2), 5.000–10.000 km (3),
10.000–20.000 km (4), 20.000–30.000 km (5), 30.000–50.000 (6),more than 50.000 km (7). In
addition, a total score for safe driving behaviour was calculated. Each safe driving behaviour
item was a driving situation that could be rated on a five-point scale ranging from not difficult
(0) to impossible to do (4), or as not applicable (no score). A mean score was calculated by
summing up all scores divided by the number of items endorsed. In addition to the driving
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questionnaire, both the informant and the participant were asked whether the participant is
still driving as safely as when the participant was middle-aged (1), is driving less safely compared
to when the participant was middle-aged (2) or drives unsafely (3). They were also both asked
whether they believed that the participant should cease driving, given the response alternatives:
no (1), questionable (2) or yes (3).
The CDR [40] consists of six subscales:memory, orientation, judgement & problem solving,
community affairs, home & hobbies and personal care. Items of all six subscales are discussed
with the informant. Subscalesmemory, orientation and judgement & problem solving also con-
tain items to discuss with the participant. For each subscale, a subscore was determined: 0 (no
impairment), 0.5 (questionable impairment), 1 (mild impairment), 2 (moderate impairment)
or 3 (severe impairment). The CDR total score was calculated with the Washington Univer-
sity’s CDR-assignment algorithm [40] giving a total score of 0, 0.5, 1, 2 or 3. Moreover, the
CDR sum of boxes score was calculated by summing up the six subscores.
Neuropsychological assessment. A neuropsychological test battery was composed aiming
to measure cognitive functions that are known to be important for driving, containing aspects
of attention, executive functioning and visuospatial abilities [21,36–39,41–43]. The neuropsy-
chological tests included both paper and pencil tests as well as computerized tests.
TheMMSE [44,45] was used as a general measure of cognition. The MMSE assesses basic
abilities of a range of cognitive functions including memory, attention and language skills. The
MMSE is widely used as a screening tool for dementia [46]. The sum score ranging from 0 to
30 was calculated.
Table 1. Characteristics of healthy participants and patients with Alzheimer’s disease.
Group
Characteristics Healthy (n = 45) AD (n = 81) P Value (df)
Age, mean (SD), y 76.3 (4.7) 72.3 (9.4) .105 a (125)
Male sex, No. (%) 24 (53.3%) 53 (65.4%) .189 b (1)
Education, mean of 7 stages (SD) 5.2 (1.3) 4.9 (1.4) .129 a (6)
CDR-score, No. (%) < .001 c (2)
0 42 (93.3%) 1 (1.2%)
0.5 3 (6.7%) 67 (82.7%)
1 0 (0.0%) 13 (16.1%)
MMSE-score, mean (SD) 28.8 (1.1) 23.2 (3.7) < .001 a (125)
Cholinergic medication, No. (%) NA 36 (44.4%)
Cholinergic medication dose, mean (SD), mg/day NA 12.7 (5.7)
Other medication affecting the CNS, No. (%) 3 (6.7%) 8 (9.9%) 1.000 b (1)
Driving experience, mean (SD), y 51.1 (8.6) 49.8 (9.5) d .378 a (122)
Driving experience, mean (SD), km 1,258,000 (1,435,000) 1,426,000 d (2,867,000) .201 a (122)
Car accident in past year, No. (%) 3 (6.7%) 5 (6.2%) 1.000 b (1)
Trafﬁc ﬁne in past year, No. (%) 9 (20.0%) 17 (21.0%) .882 c (4)
a Mann-Whitney U test
b Fisher’s Exact test
c χ2 test
d For 78 patients out of 81 patients, because 3 patients did not report the information.
Abbreviations: AD, Alzheimer’s disease; Education, Verhage scale for the Dutch educational level ranging from 1 (primary school not ﬁnished) to 7
(university level); CDR-score, Clinical Dementia Rating Total Score; MMSE-score, Mini Mental State Examination Total Score; NA, not applicable; CNS,
central nervous system; Other medication affecting the CNS include benzodiazepines, antiepileptic drugs, antidepressants and pain killers.
doi:10.1371/journal.pone.0149566.t001
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The Trailmaking Test (TMT) A and B [47] was performed as a measure of cognitive flexibil-
ity. The TMT consists of two parts, TMT A and TMT B. In TMT A, participants are instructed
to draw lines between numbers presented on a paper in ascending order as fast as possible. An
upper limit was set at five minutes. The time to completion was measured. In TMT B, partici-
pants have to draw a line between numbers and letters in ascending order, alternating between
both types of stimuli as fast as possible. An upper limit was set at six minutes. The time to com-
pletion was measured. In an attempt to remove the effects of simple sequencing, visual scan-
ning and psychomotor functioning, the time to complete TMT A was subtracted from the time
to complete TMT B (TMT B-TMT A) and this index score was taken as a measure of cognitive
flexibility [48].
Drawings [39] were included as a measure of visuoconstructive ability. Participants were
asked to draw from memory a house, a star with five points, a cube and a clock on paper. For
each drawing a maximum of two points was scored if the object was recognizable and com-
plete, resulting in a total score between 0 and 8.
TwoMazes, suggested as predictors of high crash risk in older drivers by Staplin and col-
leagues (2013)[38], were included as a measure of visual orientation. The mazes were provided
on paper. One practice maze of intermediate difficulty was completed before the two test
mazes were administered. Maze 1 was labelled by the author as “easy”, whereas maze 2 was
labelled as “difficult” [38]. For the administration of each maze, the experimenter pointed at
the starting point of the maze and instructed the participant to find the exit of the maze by
drawing a continuous line from the starting point to the exit. In case of errors, participants
were instructed to follow the line they incorrectly drew backwards until they could continue
the correct route. The time to complete each maze was measured.
The Adaptive Tachistoscopic Traffic Perception Test (ATAVT) of the Vienna Test System
(VTS)[49] was used to assess the ability to gain an overview in traffic situations. Photographs
of traffic situations were shown to the participants for approximately one second per picture
on a computer. Afterwards, the participants were asked to report what was in it, choosing at
least one out of five answer options: pedestrians, cars, (motor)cyclists, traffic signs and traffic
lights. Photographs were presented adaptively, meaning that after an initial phase, the difficulty
of the items was increasingly tailored to match the ability of the participant. The outcome mea-
sure was a performance parameter based on the 1PL Rasch model, provided by the VTS.
A traffic theory test was developed by the SWOV Institute for Road Safety Research and the
CBR Dutch driving test organisation to measure knowledge about traffic theory. A total of 28
pictures presenting traffic scenes were consecutively displayed on a computer screen. For each
scene, participants were requested to answer a question regarding the meaning of traffic signs,
priority regulations and other traffic rules. There was a time limit of twelve seconds per ques-
tion. The number of correct answers and the mean response time were registered.
A hazard perception test was used to measure hazard perception ability [50]. Traffic situa-
tions were presented by a computer as photographs taken from the driver’s point of view. The
current driving speed was also shown. Participants had to decide whether they would brake,
release the gas pedal or maintain their speed in 25 traffic situations. There was a time limit of
eight seconds for each traffic situation. This test requires timely planning and decision making
in an applied context of driving situations [50]. The number of correct answers and the mean
response time were measured.
Reaction Time (RT) S1 and S2 (VTS, Schuhfried) [51] are computer tests that measure visual
and auditory attention respectively. In RT S1, participants have to look at a black circle and
when the circle turns yellow they have to respond as quickly as possible by pressing a button.
In RT S2, participants have to respond as quickly as possible to a tone at 2000 Hz by pressing a
button. In both tests, participants have to keep their index finger on a rest button until a
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stimulus is presented, then they should lift their finger from the rest button to press the reac-
tion button. The reaction time (RT) is the time between the appearance of the stimulus and the
moment the finger leaves the rest button. Motor time (MT) is the time that elapses between the
moment the finger leaves the rest button and the moment that the reaction button is pressed.
Mean RT, mean MT, as well as the standard deviations of RT and MT were measured.
RT S3 (VTS, Schuhfried) [51] was included as a measure of inhibition. In the RT S3, a
sequence of yellow and red lights, a tone and combinations of these stimuli was presented. The
critical combination to which the participant was instructed to respond was the stimuli from
the RT S1 (yellow circle) and S2 (tone). When both, a yellow circle and a tone, were presented,
participants had to press the reaction button as quickly as possible. If only one of the stimuli
was presented or a red circle was shown, participants had to inhibit their responses. Similar to
RT S1 and S2, the mean RT, mean MT as well as the variability of RT and MT were measured.
Driving simulator rides. Five fixed-base Jentig50 driving simulators of ST Software were
used at five locations in the Netherlands. The simulators consisted of an open cabin mock-up
with a steering wheel, gear box, gas pedal, brake pedal, clutch and simulated driving sound.
Three 50 inch LED screens provided the participant with a view on the road, a view of 200° in
total. The dashboard, car windows, side mirrors and rear view mirror were realized on the
screens. During driving the participants wore the safety belt. Graphical rendering, traffic simu-
lation and system control showing a user interface for the simulator operator were running on
computers. The graphical interface was designed with StRoadDesign (ST Software) and the sce-
nario was programmed with scripting language StScenario (ST Software). Simulated traffic was
able to adapt to the behaviour of the participant [52].
Different driving simulator rides were used to assess various aspects of driving behaviour
that are assumed to be important for safe driving and that could be predictive for FTDr. After a
short practice ride, four test rides were employed, i.e. the Lane tracking ride, Intersections a,
Intersections b, and theMerging ride. All rides were driven with automatic transmission. Partic-
ipants were instructed to behave as they would drive a real car. There was a practice ride to get
acquainted with the driving simulator, especially with steering. This ride was in a rural environ-
ment on a slightly winding road with oncoming traffic on the left lane. The speed was regulated
by the computer and increased stepwise up to 100 km/h. The first test ride (Lane tracking ride)
was in the same rural environment, but the participants were in control of their own speed.
There was no speed limit. In the Lane tracking ride, participants were asked to choose a com-
fortable speed, after which they were requested to drive as if they were in a hurry. The average
speed as well as swerving, as indicated by the standard deviation of the lateral position (SDLP),
was measured twice, i.e. when participants were driving at a comfortable speed (Speed of choice,
SDLP) and when they were in a hurry (Speed in hurry, SDLP in hurry). Additionally, the num-
ber of collisions (Number of collisions) was registered during the Lane tracking ride. The second
and third test ride (Intersections a and b) were identical to each other. This ride was repeated,
because it was taken into consideration that participants may need help in identifying traffic
signs and intersections in the driving simulator at the beginning. The intersections ride was in
a rural environment, but now the participant encountered intersections with different priority
regulations. In both Intersections a and b, three intersections were analysed where the partici-
pant had to give way, including one with traffic lights. The participant was always driving
straight ahead. There was oncoming traffic on the left lane, but also traffic coming from left
and right at intersections. Furthermore, at a certain point, a car suddenly pulls out of a parking
lot in front of the participant. Speed limits differed between 60 and 80 km/h. The participants
were asked to obey the traffic rules. In the first intersections ride (Intersections a) and in the
repetition of the intersections ride (Intersections b), measures were (1) lowest speed when
approaching three intersections where the participant has to give way (Minimum speed Int
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1, 2, 3), (2) average deviation from the speed limits (Dev from speed limit), (3) brake reaction
time when the traffic lights turn yellow (RT traffic lights), (4) whether or not the participant
brakes for the car that pulls out of a parking lot (Braking for car that pulls out) and (5) the total
number of collisions (Number of collisions) in the respective intersections ride. In the fourth
and final test ride (Merging ride), the participant merged into a crowded motorway with two
lanes in each direction and was asked to overtake one vehicle and subsequently leave the
motorway. Measures were (1) speed while merging (Speed while merging), (2) deceleration of
the rear car right after merging (Deceleration rear car), (3) time headway to the car in front
right after merging (Time headway merging) and (4) the smallest time headway to any car in
front during the Merging ride (Minimum time headway)[53].
Participants were instructed to report to the researchers if they were not feeling well dur-
ing driving. After each ride, a researcher asked how the participant was feeling. If symptoms
of simulator sickness, such as dizziness or nausea, were reported or observed, participants
were advised to take a break and if their symptoms did not disappear to abort the driving
simulation.
On-road driving assessment. The on-road driving assessment was carried out in the par-
ticipant’s own car during daylight hours. The on-road driving assessments were rated by
approved experts on practical FTDr of CBR, the Dutch driving test organisation, experienced
in the assessment of people with impairments like dementia. The experts are extensively
trained to evaluate the effects of impairments on driving behaviour. They were blind to the par-
ticipant’s diagnosis, clinical ratings, neuropsychological test results, as well as driving simulator
performance. However, they did know that the participant could have cognitive problems
because they were using a specific protocol for cognitive impairment. They made use of the
Test Ride Investigating Practical fitness to drive (TRIP) forms [11,54]. The TRIP consists of 60
items, concerning lateral positioning, gap distances, speed, visual behaviour, responses to traf-
fic signs, overtaking, anticipation, communication, turning left, merging, technical execution
and perception and insight, each rated as either sufficient, doubtful, or insufficient. Finally, one
overall score was given by the expert on practical FTDr, resulting in a pass, doubtful or fail out-
come. This variable was recoded into a dichotomous item which indicates whether or not a
participant is fit to drive (FITtoDRIVE): pass outcomes indicated fitness to drive while doubtful
or fail outcomes indicated that participants are unfit to drive.
Procedure
Participants were invited to take part in the study on a voluntary basis. Patients were recruited
via multiple health care centres and from the general community by means of advertisements.
Healthy participants were recruited from the general community by means of advertisements
and word of mouth. The study was conducted according to ethical guidelines and was
approved by the Medical Ethical Committee at the University Medical Center Groningen
(METc 2012/172, ABR-nr. NL39622.04212) and the Ethical Committee Psychology at the Uni-
versity of Groningen (ppo-013-045 & ppo-012-065), the Netherlands. All participants provided
their written informed consent to participate in the study. Patients were regarded able to con-
sent themselves, since all patients were in a mild stage of dementia. In addition, verbal consent
was asked from the participant and the informant when the study was explained verbally at the
start. The Ethical Committees approved this consent procedure. Patients received no direct
reward for participation, but patients who passed the on-road driving assessment could use
this outcome in an official relicensing procedure. Healthy participants were rewarded 15 Euros
for participation.
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Participants were invited twice. On the first occasion, clinical interviews with the participant
and an informant were conducted, as well as the neuropsychological assessment and the driv-
ing simulator rides. On the second occasion, the on-road driving assessment took place. The
participant invited an informant of their choice, which was in most cases their partner and oth-
erwise one of their children, caretakers or friends. Participants were instructed to fill out the
driving questionnaire with the help of the informant beforehand and bring the questionnaire
with them to the first session. During that first session, an interviewer conducted the clinical
interview with the informant in absence of the participant. The driving questionnaire was dis-
cussed with the informant in case of ambiguous items. Meanwhile an experimenter instructed
the participant for the neuropsychological assessment. After the neuropsychological assess-
ment, the interviewer conducted the clinical interview with the participant in absence of the
informant. Finally, the driving simulator rides were performed.
During the first session, participants were also screened to assure that they met the mini-
mum requirements for the on-road driving assessment with regard to visual and motor func-
tions. Reported medication use was also checked for not using category 3 medications, which
are classified as having a severe influence on driving ability [55]. The first session lasted
approximately four hours in total, including around half an hour driving simulation. The sec-
ond session, the on-road driving assessment, was performed by the participant on another day
and took around 45 minutes.
Statistical analyses
Data cleaning and missing value analysis. Analyses were performed with IBM SPSS Sta-
tistics 22. The few missing values of the clinical interviews were not replaced. Missing values
occurred in the judgement of the informant about how safe the participant drives and the opin-
ion of the informant whether the participant should cease driving (two cases) and the mean
score for safe driving behaviour (six cases).
Missing values occurred in the neuropsychological assessment when participants exceeded a
certain number of incorrect responses or failed to complete a test within the given time limits.
These missing values were imputed by the worst scores of the respective group that did com-
plete the test. Such imputations were made for TMT A (one case), TMT B (31 cases), Maze 1
(two cases) and RT S3 (three cases).
Twenty-three participants (28.4%) with AD reported feelings of dizziness or nausea indicat-
ing simulator sickness and were excluded entirely from analyses that involved driving simulator
rides. Driving simulator data of two other participants with AD were missing; one patient was
unable to steer the driving simulator, the other patient was panicking in the driving simulator
and both patients had to stop driving. Due to a technical error, driving simulator data of the
third ride of one patient are missing. Twenty-four healthy participants (53.3%) reported simu-
lator sickness and were excluded entirely from analyses that involved driving simulator rides.
Four driving simulator variables (see explanation below) were occasionally missing although
the participant had driven all driving simulator rides. In the group of patients, in both intersec-
tion rides, the brake reaction time to the traffic lights was missing in 11 cases. In the healthy
comparison group, this variable was missing in five cases in the first intersection ride only.
These missing values are omission errors of participants who did not notice the traffic lights,
therefore the worst scores of the respective group that did brake were inserted. If participants
merged on the motorway after all cars had passed, there are no values for the deceleration of
the rear car. In the group of patients, these missing values occurred in seven cases and values
were inserted using an imputation model (including all complete variables of the driving simu-
lator) that was estimated by maximum likelihood (ML), providing a singly imputed dataset.
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Group comparisons. Patients with AD and healthy participants were compared using
separate MANOVAs for the clinical interviews, neuropsychological assessment and driving
simulator rides. Significance level alpha was initially set to .05. However, alpha level was
adjusted by using Bonferroni-Holm correction in order to control for alpha error inflation in
multiple comparisons. Furthermore, effect sizes were calculated for multivariate and univariate
comparisons (indicated by η2 and Cohen’s d). The index η2 provides information about the
proportion of variance which is accounted for by the multivariate comparisons. As described
by Cohen [56], η2 is a function of the effect size index f. According to Cohen [56], a small effect
size (f = .10) corresponds to an η2 = .0099, a medium effect size (f = .25) to an η2 = .0588 and a
large effect size (f = .40) to an η2 = .1379. The effect size Cohen’s d was computed for univariate
comparisons. Negligible effects (d< 0.20), small effects (0.20< d< 0.50), medium effects
(0.50< d< 0.80) and large effects (d> 0.80) were distinguished. A similar procedure was per-
formed to compare patients who passed the on-road driving assessment with patients who
failed the on-road driving assessment.
Development of prediction models for fitness to drive. The goal of the present analysis
was to predict fitness to drive as indicated by the dichotomous variable FITtoDRIVE. Predic-
tion is a statistical term meaning that the dependent variable FITtoDRIVE is hypothesized to
be influenced by the independent variables. The independent variables (predictor variables)
were divided into three groups, e.g. clinical interviews, neuropsychological assessment and
driving simulator rides, in order to explore the accuracy of each group of variables in predicting
fitness to drive. For each group of predictor variables, the first analyses involved correlations
with FITtoDRIVE (point biserial correlation coefficients). Predictor variables correlating sig-
nificantly (p<0.05) with FITtoDRIVE were selected for the second analyses, i.e. binary logistic
regressions with a forward inclusion method. Binary logistics were performed to determine the
validity of each respective group of predictor variables in predicting FITtoDRIVE. In order not
to lose predictive power, a liberal entry criterion for predictor variables (p<0.20) was used. Pre-
dictor variables included by the regression model were used in the third step, i.e. Discriminant
Function Analysis (DFA). In DFA, selected predictor variables are weighted determining their
utility to distinguish between fit and unfit to drive (FITtoDRIVE). A prediction equation for
each group of predictors was developed by summing up the predictor variables multiplied with
the corresponding unstandardized discriminant coefficients. This resulted in three predictor
variables representing the clinical interviews, the neuropsychological assessment and the driv-
ing simulator rides. Finally, receiver operating characteristic (ROC) analyses were carried out
to test the accuracy of the developed variables in predicting FITtoDRIVE. In an ROC analysis,
a curve is created by plotting the sensitivity against the specificity of the predictor variable. The
area under the curve (AUC) is used as a classification measure with larger areas indicating bet-
ter predictive accuracy.
Comparison and combination of prediction models. In order to compare the three pre-
diction models described above, patients with data of the complete assessment procedure,
including clinical interviews, neuropsychological assessment and driving simulator rides, were
selected (n = 55). On this group of patients, three separate ROC analyses were performed using
the three developed predictor variables explained above. The resulting AUCs give information
about which predictor variable holds the best predictive accuracy. Furthermore, the three pre-
dictor variables were entered in a hierarchical binary logistic regression analysis to investigate
whether using more than one type of assessment would improve the predictive accuracy.
According to the common procedure in clinical practice, the predictor variable of clinical inter-
views was entered in block 1, the predictor variable of neuropsychological assessment was
entered in block 2 and the predictor variable of driving simulator rides was entered in block 3.
If neuropsychological test performance or driving simulator performance were shown to
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significantly add predictive validity in hierarchical logistic regression, DFA was performed as
described above to create a final predictor variable for the prediction of FITtoDRIVE integrat-
ing all information from the three types of assessments. This final predictor variable was used
in an ROC analysis which revealed the accuracy of classification of the complete method. The
predictive accuracy was further evaluated by calculating the sensitivity, specificity, positive pre-
dictive power and negative predictive power using various cut-offs. In order to create one num-
ber showing the highest combination of sensitivity and specificity, Youden’s indexes were
calculated by sensitivity + specificity -1 [57].
Results
Group comparisons between healthy individuals and patients with AD
Significant differences were found between patients with AD and healthy participants with
regard to clinical interviews (Wilk’s lambda = 0.401, F(12,103) = 12.841, p< .001, η2 = .599),
neuropsychological assessment (Wilk’s lambda = 0.347, F(23,97) = 7.926, p< .001, η2 = .653),
and driving simulator rides (Wilk’s lambda = 0.488, F(22,55) = 2.624, p = .002, η2 = .512). In
the clinical interviews, patients with AD scored significantly higher than healthy participants
on five of the six subscores of the CDR (subscore personal care is the exception) as well as on
the sum of boxes score. In the neuropsychological assessment, patients with AD performed sig-
nificantly poorer than healthy participants on all neuropsychological tests except for Drawings.
During the first ride in the driving simulator, patients with AD swerved (indicated by SDLP)
significantly more and drove significantly slower when they were in a hurry than healthy par-
ticipants. During Intersections a, the deviance from the speed limit differed between the groups
and again patients with AD were driving slower than healthy participants. Pairwise compari-
sons are presented in Table 2. The pass rates on the on-road assessment also differed between
patients with AD and healthy participants (χ2(2) = 28.22, p< .001). In the group of patients
with AD, 35 (43.2%) patients passed the on-road assessment, 5 (6.2%) patients had a doubtful
outcome and 41 (50.6%) patients failed. In the healthy comparison group, 40 (88.9%) partici-
pants passed the on-road assessment, 3 (6.7%) had a doubtful outcome and 2 (4.4%) failed the
on-road assessment.
Fitness to drive of people with AD
The patients with AD were divided into a pass and a fail group. The pass group entailed the 35
(43.2%) patients who passed the on-road assessment. The fail group included the other 46
(56.8%) patients and included both the patients who had a doubtful outcome and the patients
who failed the on-road assessment. MANOVA revealed significant differences between the
pass and fail group with regard to clinical interviews (Wilk’s lambda = 0.655, F(12,60) = 2.635,
p = .007, η2 = .345), neuropsychological assessment (Wilk’s lambda = 0.426, F(23,52) = 3.047,
p< .001, η2 = .574), and driving simulator rides (Wilk’s lambda = 0.419, F(22,33) = 2.077, p =
.028, η2 = .581). In the clinical interviews, the fail group scored significantly higher on the CDR
subscore judgement & problem solving as well as on the sum of boxes score than the pass group.
Moreover, the fail group had driven less kilometres in the past twelve months (indicated by
recent driving experience) than the pass group. The fail group performed significantly worse
than the pass group on seven neuropsychological tests, including the MMSE, Drawings, Maze
2, RT S1, RT S2, Hazard perception and Traffic theory. In the driving simulator rides, there
was one significant difference showing that in the fail group the car driving behind the patient
needed to slow down much more to avoid a collision after the patient merged on the motorway
than in the pass group. Pairwise comparisons are presented in Table 3.
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Table 2. Comparison of healthy participants with patients with Alzheimer’s disease (AD) on clinical interviews, neuropsychological assessment,
and driving simulator rides.
Clinical interviews Healthy (n = 43) AD (n = 73) F p a ES b
Clinical Dementia Rating
Memory 0.035±0.129 0.801±0.462 112.8 < .001 * 2.04
Orientation 0.023±0.153 0.719±0.527 71.2 < .001 * 1.62
Judgement & Problem solving 0.023±0.107 0.630±0.493 63.2 < .001 * 1.53
Community affairs 0.000±0.000 0.356±0.282 68.2 < .001 * 1.59
Home & Hobbies 0.000±0.000 0.336±0.364 36.5 < .001 * 1.16
Personal care 0.000±0.000 0.034±0.174 1.672 .199 0.25
Sum of boxes 0.081±0.326 2.877±1.565 133.3 < .001 * 2.22
Heteroanamnesis
Judgement driving safety 1.07±0.34 1.27±0.51 5.5 .021 0.44
Opinion cease driving 1.00±0.00 1.21±0.53 6.5 .012 0.50
Anamnesis
Judgement driving safety 1.07±0.26 1.08±0.28 0.1 .811 0.04
Opinion cease driving 1.00±0.00 1.01±0.12 0.6 .445 0.11
Driving questionnaire
Mean score 0.37±0.30 0.27±0.28 3.1 .079 0.34
Recent driving experience 2.98±1.10 2.62±1.05 3.1 .082 0.34
Neuropsychological assessment Healthy (n = 45) AD (n = 76) F p a ES b
MMSE
Total score 28.82±1.093 23.42±3.634 94.1 < .001 * 1.82
TMT
TMT B-TMT A (sec) 63.33±33.20 164.49±88.14 54.5 < .001 * 1.39
Drawings
Total score 6.40±1.24 5.91±1.69 2.9 .091 0.32
Mazes
Maze 1, time (sec) 5.24±2.24 16.12±17.95 16.3 < .001 * 0.76
Maze 2, time (sec) 16.58±7.27 37.39±29.92 21.0 < .001 * 0.86
RT S1
Reaction time (msec) 303.76±59.93 399.28±141.61 18.5 < .001 * 0.81
Motor time (msec) 241.38±67.05 302.91±108.89 11.7 .001 * 0.64
Variability in reaction time 42.40±21.25 73.84±67.64 9.2 .003 * 0.57
Variability in motor time 39.47±16.57 52.97±27.24 9.1 .003 * 0.57
RT S2
Reaction time (msec) 257.22±55.34 322.24±121.01 11.5 .001 * 0.64
Motor time (msec) 211.24±52.65 253.20±101.18 6.7 .011 * 0.49
Variability in reaction time 39.84±14.87 63.78±49.45 10.0 .002 * 0.59
Variability in motor time 28.42±10.25 39.01±21.32 9.7 .002 * 0.59
RT S3
Reaction time (msec) 514.24±92.30 710.08±288.92 19.4 < .001 * 0.83
Motor time (msec) 266.89±71.53 336.55±156.27 7.9 .006 * 0.53
Variability in reaction time 84.33±24.66 156.70±100.65 22.4 < .001 * 0.89
Variability in motor time 36.89±14.78 59.09±47.24 9.4 .003 * 0.58
ATAVT
Performance parameter -5.712±9.532 -15.475±11.431 23.2 < .001 * 0.91
Hazard perception
Response time (sec) 4.36±0.64 5.51±0.78 69.7 < .001 * 1.57
(Continued)
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Prediction of fitness to drive of patients with AD
Prediction of fitness to drive using clinical interviews. First, we examined which inde-
pendent variables (possible predictor variables) from the clinical interviews were correlating (α
= .05) with FITtoDRIVE. Variables of the CDR that correlated significantly with FITtoDRIVE
were subscoresmemory (r = -.259, p = .020), orientation (r = -.313, p = .004), judgement &
problem solving (r = -.414, p< .001) and community affairs (r = -.253, p = .023) as well as the
sum of boxes score (r = -.417, p< .001). Furthermore, significant correlations with FITtoD-
RIVE were found for the informant’s opinion whether the patient should cease driving (r =
-.273, p = .015), for the patient’s judgement of one’s own driving safety (r = -.229, p = .040) and
Table 2. (Continued)
Correct trials 15.76±2.08 13.47±3.20 18.3 < .001 * 0.81
Trafﬁc theory
Response time (sec) 6.42±1.09 7.67±1.06 37.8 < .001 * 1.16
Correct trials 21.20±3.40 18.09±3.24 25.1 < .001 * 0.94
Driving simulator rides Healthy (n = 22) AD (n = 56) F p a ES b
Lane tracking ride
Speed of choice (km/h) 79.05±6.65 70.92±12.79 8.0 .006 0.71
SDLP (cm) 21.26±6.33 27.81±8.18 11.4 .001 * 0.85
Speed in hurry (km/h) 90.04±8.26 80.31±12.50 11.3 .001 * 0.85
SDLP in hurry (cm) 23.00±6.51 27.06±7.70 4.8 .032 0.55
Number of collisions 0.0±0.0 0.0±0.0 NA NA NA
Intersections a
Minimum speed Int 1 (km/h) 14.36±22.67 12.81±18.37 0.1 .756 0.08
Minimum speed Int 2 (km/h) 10.78±19.05 14.27±22.40 0.4 .521 0.16
Minimum speed Int 3 (km/h) 8.01±15.96 10.61±17.75 0.4 .551 0.15
Dev from speed limit (km/h) -3.42±3.81 -8.85±7.30 10.9 .001 * 0.84
RT trafﬁc lights (sec) 1.47±0.94 2.38±2.08 3.8 .055 0.49
Braking for car that pulls out 0.41±0.50 0.52±0.50 0.7 .394 0.22
Number of collisions 0.82±0.91 0.55±0.78 1.6 .204 0.33
Intersections b
Minimum speed Int 1 (km/h) 3.56±5.84 13.17±19.10 5.3 .024 0.58
Minimum speed Int 2 (km/h) 0.63±1.24 19.24±30.35 8.2 .005 0.72
Minimum speed Int 3 (km/h) 4.57±10.09 18.19±23.24 7.0 .010 0.67
Dev from speed limit (km/h) -3.19±4.55 -7.34±8.56 4.6 .035 0.55
RT trafﬁc lights (sec) 0.96±0.66 2.11±1.77 8.7 .004 0.74
Braking for car that pulls out 0.50±0.51 0.52±0.50 0.0 .889 0.04
Number of collisions 0.36±0.58 0.38±0.59 0.0 .939 0.03
Merging ride
Speed while merging (km/h) 85.75±13.74 84.11±13.71 0.2 .636 0.12
Deceleration rear car (km/h) -1.10±2.00 -1.10±1.77 0.0 .999 0.00
Time headway merging (sec) 1.26±0.79 1.13±0.67 0.5 .472 0.18
Minimum time headway (sec) 0.33±0.33 0.41±0.36 0.9 .338 0.24
a Statistical signiﬁcance is indicated by *. Signiﬁcance level of .05 was corrected using the Bonferroni-Holm procedure.
b Effect size (ES) is indicated by Cohen’s d.
Abbreviations: MMSE, Mini Mental State Examination; TMT, Trailmaking Test; RT, Reaction time; ATAVT, Adaptive Tachistoscopic Trafﬁc Perception
Test; SDLP, standard deviation of lateral position; NA, not applicable; Int, intersection with need to give right of way; Dev, deviance.
doi:10.1371/journal.pone.0149566.t002
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Table 3. Comparison of patients with Alzheimer’s disease (AD) who pass and patients with AD who fail the on-road test on clinical interviews,
neuropsychological assessment, and driving simulator rides.
Clinical interviews Pass (n = 35) Fail (n = 38) F p a ES b
Clinical Dementia Rating
Memory 0.671±0.382 0.921±0.500 5.6 .020 0.56
Orientation 0.543±0.460 0.882±0.538 8.2 .005 0.68
Judgement & Problem solving 0.400±0.292 0.842±0.547 18.1 < .001 * 1.00
Community affairs 0.286±0.251 0.421±0.297 4.4 .040 0.49
Home & Hobbies 0.271±0.329 0.395±0.388 2.1 .149 0.34
Personal care 0.014±0.085 0.053±0.226 0.9 .349 0.23
Sum of boxes 2.186±0.971 3.513±1.742 15.8 < .001 * 0.93
Heteroanamnesis
Judgement driving safety 1.17±0.38 1.37±0.59 2.8 .098 0.40
Opinion cease driving 1.09±0.37 1.32±0.62 3.6 .061 0.45
Anamnesis
Judgement driving safety 1.03±0.17 1.13±0.34 2.6 .112 0.37
Opinion cease driving 1.03±0.17 1.00±0.00 1.1 .301 0.26
Driving questionnaire
Mean score 0.24±0.22 0.31±0.32 1.1 .292 0.25
Recent driving experience 3.03±1.04 2.24±0.91 12.0 .001 * 0.81
Neuropsychological assessment Pass (n = 35) Fail (n = 41) F p a ES b
MMSE
Total score 25.11±2.23 21.98±3.98 17.1 < .001 * 0.95
TMT
TMT B-TMT A (sec) 144.51±90.02 181.54±83.85 3.4 .068 0.43
Drawings
Total score 6.69±1.29 5.24±1.71 16.7 < .001 * 0.94
Mazes
Maze 1, time (sec) 12.17±16.29 19.49±18.80 3.2 .076 0.41
Maze 2, time (sec) 26.40±22.43 46.78±32.48 9.8 .003 * 0.72
RT S1
Reaction time (msec) 350.69±84.33 440.76±166.52 8.4 .005 0.67
Motor time (msec) 260.54±74.28 339.07±120.96 11.2 .001 * 0.77
Variability in reaction time 57.69±29.15 87.63±86.21 3.8 .054 0.45
Variability in motor time 49.77±21.32 55.71±31.44 0.9 .347 0.22
RT S2
Reaction time (msec) 272.74±51.21 364.49±145.79 12.5 .001 * 0.81
Motor time (msec) 208.94±68.28 290.98±109.79 14.7 < .001 * 0.88
Variability in reaction time 48.69±20.33 76.66±62.16 6.5 .013 0.59
Variability in motor time 32.77±15.90 44.34±23.96 5.9 .017 0.56
RT S3
Reaction time (msec) 620.51±231.82 786.54±312.77 6.7 .012 0.60
Motor time (msec) 283.34±127.09 381.98±165.73 8.2 .005 0.66
Variability in reaction time 132.34±84.65 177.49±109.28 3.9 .051 0.46
Variability in motor time 44.49±34.09 71.56±53.40 6.7 .012 0.59
ATAVT
Performance parameter -13.181±10.500 -17.433±11.948 2.7 .106 0.38
Hazard perception
Response time 5.30±0.71 5.69±0.80 5.1 .027 0.52
(Continued)
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recent driving experience (r = .424, p< .001). This selection of variables was entered to a for-
ward binary logistic regression analysis to determine the validity of the predictor variables in
predicting FITtoDRIVE. A significant model was found to predict FITtoDRIVE, χ2(4, N = 79)
= 31.604, p< .001, on the basis of CDR subscores orientation and judgement & problem solv-
ing, the patient’s own judgement about driving safety and recent driving experience. The
model explained 33.0% of the total variance (Cox & Snell R2) and classified 73.4% of the
patients correctly as fit or unfit to drive. A summary of the forward logistic regression analysis
with the predictor variables from the clinical interviews is presented in Table 4. Subsequently, a
DFA was conducted on the basis of the variables suggested by the logistic regression predicting
FITtoDRIVE. A significant model emerged (Wilk’s lambda = 0.673, χ2(4) = 30.486, p< .001,
Table 3. (Continued)
Correct trials 15.20±2.87 12.00±2.71 24.9 < .001 * 1.15
Trafﬁc theory
Response time 7.18±0.94 8.08±1.00 16.0 < .001 * 0.92
Correct trials 19.11±2.64 17.22±3.48 7.0 .010 0.61
Driving simulator rides Pass (n = 28) Fail (n = 28) F p a ES b
Lane tracking ride
Speed of choice (km/h) 71.07±10.66 70.78±14.82 0.0 .932 0.02
SDLP (cm) 26.56±6.49 29.05±9.53 1.3 .257 0.31
Speed in hurry (km/h) 81.35±12.25 79.27±12.89 0.3 .540 0.17
SDLP in hurry (cm) 25.60±5.94 28.51±9.01 2.0 .159 0.51
Number of collisions 0.0±0.0 0.0±0.0 NA NA NA
Intersections a
Minimum speed Int 1 (km/h) 11.05±15.77 14.57±20.80 0.5 .478 0.19
Minimum speed Int 2 (km/h) 6.89±17.04 21.66±24.87 6.7 .012 0.69
Minimum speed Int 3 (km/h) 7.88±15.09 13.35±19.96 1.3 .252 0.31
Dev from speed limit (km/h) -8.50±6.14 -9.20±8.40 1.1 .722 0.10
RT trafﬁc lights (sec) 1.71±1.59 3.04±2.32 6.3 .015 0.67
Braking for car that pulls out 0.57±0.50 0.46±0.51 0.6 .432 0.22
Number of collisions 0.32±0.55 0.79±0.92 5.3 .025 0.62
Intersections b
Minimum speed Int 1 (km/h) 10.93±16.27 15.42±21.63 0.8 .385 0.23
Minimum speed Int 2 (km/h) 10.24±24.02 28.25±33.62 5.3 .025 0.62
Minimum speed Int 3 (km/h) 12.98±19.43 23.40±25.82 2.9 .093 0.46
Dev from speed limit (km/h) -7.47±7.71 -7.21±9.48 0.0 .909 0.03
RT trafﬁc lights (sec) 1.51±1.56 2.71±1.80 7.1 .010 0.71
Braking for car that pulls out 0.68±0.48 0.36±0.49 6.2 .016 0.66
Number of collisions 0.25±0.52 0.50±0.64 2.6 .113 0.43
Merging ride
Speed while merging (km/h) 88.00±12.32 80.22±14.13 4.8 .032 0.59
Deceleration rear car (km/h) -0.33±0.79 -1.87±2.13 12.9 .001 * 0.96
Time headway merging (sec) 0.90±0.60 1.36±0.66 7.5 .008 0.73
Minimum time headway (sec) 0.33±0.18 0.50±0.47 3.4 .072 0.49
a Statistical signiﬁcance is indicated by *. Signiﬁcance level of .05 was corrected using the Bonferroni-Holm procedure.
b Effect size (ES) is indicated by Cohen’s d.
Abbreviations: MMSE, Mini Mental State Examination; TMT, Trailmaking Test; RT, Reaction time; ATAVT, Adaptive Tachistoscopic Trafﬁc Perception
Test; SDLP, standard deviation of lateral position; NA, not applicable; Int, intersection with need to give right of way; Dev, deviance.
doi:10.1371/journal.pone.0149566.t003
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Table 4. Summary of forward logistic regression analyses of predictor variables from the clinical interviews, neuropsychological assessment and
driving simulator rides on fitness to drive for patients with Alzheimer’s disease.
Predictor variables B SE B Wald p Odds ratio
Clinical interviews
Model
CDR Orientation -1.088 -0.603 3.254 .071 0.337
CDR Judgement & Problem solving -1.840 0.856 4.622 .032 0.159
Anamnesis Judgement driving safety -1.470 1.153 1.627 .202 0.230
Recent driving experience 0.710 0.293 5.887 .015 2.035
Total R2 = 0.330*
Excluded variables Score
CDR Memory 0.324 .569
CDR Community affairs 1.531 .216
CDR Sum of boxes score 0.109 .742
Heteroanamnesis Opinion cease driving 0.429 .513
Neuropsychological assessment
Model
MMSE 0.277 0.118 5.536 .019 1.319
RT S2 RT -0.011 0.005 4.734 .030 0.989
Hazard perception Correct trials 0.411 0.138 8.903 .003 1.508
Trafﬁc theory Response time -0.493 0.334 2.174 .140 0.611
Total R2 = 0.444*
Excluded variables Score
TMT B-TMT A 0.091 .763
Drawings 1.582 .208
Maze 2 time 0.323 .570
RT S1 RT 0.013 .910
RT S1 MT 1.265 .261
RT S1 Variability in RT 0.788 .375
RT S2 MT 1.709 .191
RT S2 Variability in RT 3.439 .064
RT S2 Variability in MT 0.045 .831
RT S3 RT 0.029 .865
RT S3 MT 0.233 .629
RT S3 Variability in RT 0.018 .892
RT S3 Variability in MT 0.376 .540
Hazard perception Response time 2.284 .131
Trafﬁc theory Correct trials 1.000 .317
Driving simulator rides
Model
Minimum speed at intersection 2 in Int a -0.030 0.017 3.159 .075 0.970
Number of collisions in Int a -1.066 0.494 4.656 .031 0.345
Deceleration of rear car after merging 0.679 0.333 4.163 .041 1.971
Time headway after merging -0.991 0.637 2.421 .120 0.371
Total R2 = 0.377*
Excluded variables Score
RT trafﬁc lights in Int a 0.223 .637
Minimum speed at intersection 2 in Int b 0.003 .959
RT trafﬁc lights in Int b 0.468 .494
(Continued)
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r = .572). A prediction equation was generated by summating predictor variables weighted
with their unstandardized canonical discriminant coefficients: CDR orientation x 0.675 + CDR
judgement & problem solving x 1.036 + Judgement of patient about driving safety x 1.250
+ Recent driving experience x -0.576. With this prediction equation, a new predictor variable
for the clinical interviews was created. The accuracy of the predictor variable for the clinical
interviews in detecting patients who are unfit to drive (n = 46) relative to patients who are fit to
drive (n = 35) was examined by means of an ROC analysis. A significantly higher accuracy
than chance of detecting patients who are unfit to drive was revealed (AUC = .835, SE = 0.044,
p< .001).
Prediction of fitness to drive using neuropsychological assessment. Variables of paper-
and-pencil tests that correlated significantly with FITtoDRIVE were the MMSE (r = .459,
p< .001), TMT B-TMT A (r = -.230, p = .039), Drawings (r = .439, p< .001) and Maze 2 (r =
-.333, p = .003). Of the RT tests, all variables describing RT (RT S1: r = -.309, p = .005; RT S2:
r = -.369, p = .001; RT S3: r = -.282, p = .012), MT (RT S1: r = -.342, p = .002; RT S2: r = -.399,
p< .001; RT S3: r = -.294, p = .008) and variability in RT (RT S1: r = -.222, p = .047; RT S2: r =
-.287, p = .009; RT S3: r = -.234, p = .038) and variability in MT (RT S2: r = -.250, p = .024; RT
S3: r = -.266, p = .018) correlated with FITtoDRIVE except the variability in MT of RT S1. Fur-
thermore, significant correlations with FITtoDRIVE were found for the response time (r =
-.265, p = .017) and the number of correct trials (r = .510, p< .001) of the hazard perception
test, as well as the response time (r = -.385, p< .001) and the number of correct trials (r = .269,
p = .016) of the traffic theory test. Again, the correlating variables were used in a forward binary
logistic regression analysis to determine the validity of the predictor variables in predicting
FITtoDRIVE. A significant model was found to predict FITtoDRIVE, χ2(4, N = 77) = 45.149,
p< .001, on the basis of the MMSE, RT S2 RT, correct trials of the hazard perception test and
the response time in the traffic theory test. The model explained 44.4% of the total variance
(Cox & Snell R2) and classified 81.8% of the patients correctly as fit or unfit to drive. A sum-
mary of the forward logistic regression analysis with the predictor variables from the neuropsy-
chological assessment is presented in Table 4. Afterwards, a DFA was performed on the basis
of the variables suggested by the logistic regression predicting FITtoDRIVE. The DFA resulted
in a significant model (Wilk’s lambda = 0.601, χ2(4) = 38.717, p< .001, r = .632). A prediction
equation was generated by summating predictor variables weighted with their unstandardized
canonical discriminant coefficients: MMSE x 0.129 + RT S2 RT x -0.003 + Correct trials of
Hazard perception x 0.206 + Response time of Traffic theory x -0.310. The accuracy of the pre-
dictor variable for neuropsychological assessment in detecting patients who are unfit to drive
(n = 45) relative to patients who are fit to drive (n = 35) was examined using an ROC analysis.
A significantly higher accuracy than chance of detecting patients who are unfit to drive was
revealed (AUC = .905, SE = 0.035, p< .001).
Table 4. (Continued)
Predictor variables B SE B Wald p Odds ratio
Braking for car that pulls out in Int b 1.885 .170
Speed while merging 2.024 .155
Abbreviations: MMSE, Mini Mental State Examination; TMT, Trailmaking Test; RT, Reaction time; MT, Motor time; Int a, ﬁrst intersections ride; Int b,
second intersections ride;
* Cox & Snell R2.
doi:10.1371/journal.pone.0149566.t004
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Prediction of fitness to drive using driving simulator rides. Variables of the driving sim-
ulator rides that correlated significantly with FITtoDRIVE were in Intersections a Minimum
speed Int 2 (r = -.333, p = .012), RT traffic lights (r = -.323, p = .015) and Number of collisions
(r = -.299, p = .025), in Intersections b Minimum speed at Int 2 (r = -.318, p = .016), RT traffic
lights (r = -.358, p = .006) and Braking for car that pulls out (r = .334, p = .011) and in the
Merging ride, Speed while merging (r = .286, p = .031), Deceleration rear car (r = .446, p =
.001) and Time headway merging (r = -.367, p = .005). With these variables, a forward binary
logistic regression analysis was performed to determine the validity of the predictor variables
in predicting FITtoDRIVE. A significant model was found to predict FITtoDRIVE, χ2(4,
N = 56) = 26.461, p< .001, on the basis of Minimum speed Int 2 (with high values indicating
unsafe driving) and Number of collisions in Intersections a, Deceleration rear car and Time
headway merging in the Merging ride. The model explained 37.7% of the total variance (Cox &
Snell R2) and classified 75.0% of the patients correctly as fit or unfit to drive. A summary of the
forward logistic regression analysis with the predictor variables from the driving simulator
rides is presented in Table 4. Successively, a DFA was conducted based on the variables
included by the regression model to predict FITtoDRIVE. Using DFA, a significant model was
found (Wilk’s lambda = 0.617, χ2(4) = 25.151, p< .001, r = .619). A prediction equation was
generated by summating predictor variables weighted with their unstandardized canonical dis-
criminant coefficients: Minimum speed Int 2 in Intersections a x 0.021 + Number of collisions
in Intersections a x 0.738 + Deceleration rear car in the Merging ride x -0.367 + Time headway
merging in the Merging ride x 0.732. The accuracy of the predictor variable for driving simula-
tor rides in detecting patients who are unfit to drive (n = 28) relative to patients who are fit to
drive (n = 28) was examined by an ROC analysis. A significantly higher accuracy than chance
of detecting patients who are unfit to drive was revealed (AUC = .861, SE = 0.047, p< .001).
Comparing prediction models of fitness to drive. In order to compare the three predic-
tion models in their accuracy to identify patients who are unfit to drive, patients with complete
data on all three types of assessments were selected (n = 55). The accuracy of the predictor vari-
ables for clinical interviews, neuropsychological assessment and driving simulator rides in
detecting patients who are unfit to drive (n = 27) relative to patients who are fit to drive
(n = 28) were examined by ROC analyses. Though all predictor variables add significant accu-
racy compared to prediction on chance level, a comparison of prediction accuracies demon-
strated that neuropsychological assessment was the best in identifying patients unfit to drive
(AUC = .946, SE = 0.029, p< .001), followed by driving simulator rides (AUC = .856,
SE = 0.049, p< .001), and clinical interviews (AUC = .796, SE = 0.060, p< .001). A visual com-
parison of ROC curves for the three prediction models is presented in Fig 1.
Combining prediction models of fitness to drive. The three predictor variables were
entered in a hierarchical binary logistic regression analysis to investigate whether using more
than one type of assessment improves the predictive accuracy in detecting patients being unfit
to drive. According to the common procedure in clinical practice, the predictor variable of clin-
ical interviews was entered in block 1 (χ2(1, N = 55) = 41.110, p< .001), the predictor variable
of neuropsychological assessment was entered in block 2 (χ2(2, N = 55) = 48.527, p< .001)
and the predictor variable of driving simulator rides was entered in block 3 (χ2(3, N = 55) =
52.477, p< .001). The model increased significantly in predictive validity with each step, i.e.
the model of block 1 explained 52.6% of the total variance (Cox & Snell R2), the model of block
2 added 6.0% to the explained variance (Cox & Snell R2 = 58.6%) and the model of block 3
added another 2.9% to the explained variance (Cox & Snell R2 = 61.5%). With the model of
block 3, 87.3% of the patients were correctly classified as fit or unfit to drive. Subsequently, a
DFA was conducted with all three predictor variables and FITtoDRIVE, which resulted in a
significant model (Wilk’s lambda = 0.412, χ2(3) = 45.720, p< .001, r = .767). A prediction
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equation was generated by summating all variables weighted by their unstandardized canonical
discriminant coefficients: Clinical interviews x 0.328 + Neuropsychological assessment x -0.620
+ Driving simulator rides x 0.483. With this prediction equation, a final predictor variable was
created representing the complete method. The accuracy of this predictor variable in detecting
patients being unfit to drive (n = 27) relative to patients being fit to drive (n = 28) was exam-
ined by means of an ROC analysis. A high accuracy of detecting patients who are unfit to drive
was revealed (AUC = .974, SE = 0.018, p< .001). A graphical plot of the ROC curve represent-
ing the final predictor variable is shown in Fig 2.
In order to determine a suitable cut-off for the final predictor variable, a range of cut-offs
were explored in terms of their classification accuracies, including sensitivity, specificity, posi-
tive predictive value (PPV) and negative predictive value (NVP) (Table 5). When aiming for
the highest possible combination of sensitivity and specificity (as indicated by Youden’s index
[57]), the best cut-off is -0.6. Applying this cut-off, 51 out of 55 patients were classified cor-
rectly, corresponding to a predictive accuracy of 92.7%, with 3 patients incorrectly classified as
failing (false negative) and 1 patient incorrectly classified as passing (false positive) (Table 6).
However, one could also argue that it has highest priority to correctly identify patients who are
unfit to drive, resulting in a best cut-off of -0.8. With this cut-off, 50 out of 55 patients were
Fig 1. ROC curves of the predictor variables of the clinical interviews, neuropsychological assessment and driving simulator rides.
doi:10.1371/journal.pone.0149566.g001
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Fig 2. ROC curve of the predictor variable of the complete method.
doi:10.1371/journal.pone.0149566.g002
Table 5. Classification accuracy of the final predictor variable (including clinical interviews, neuropsychological assessment and driving simula-
tor rides) in detecting patients being unfit to drive (n = 27) relative to patients being fit to drive (n = 28).
Cut-off ﬁnal predictor variable Sensitivity Speciﬁcity Youden’s index PPV NPV
-0.8 100.0 82.1 0.821 84.4 100.0
-0.7 96.3 85.7 0.820 86.7 96.0
-0.6 96.3 89.3 0.856 89.7 96.2
-0.5 88.9 89.3 0.782 88.9 89.3
-0.4 88.9 92.9 0.818 92.3 89.7
-0.3 81.5 92.9 0.744 91.7 83.9
-0.2 81.5 92.9 0.744 91.7 83.9
-0.1 81.5 92.9 0.744 91.7 83.9
0.0 77.8 92.9 0.707 91.3 81.3
0.1 74.1 92.9 0.670 90.9 78.8
0.2 70.4 92.9 0.633 90.5 76.5
Abbreviations: PPV, positive predictive value; NPV, negative predictive value
doi:10.1371/journal.pone.0149566.t005
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classified correctly, corresponding to a predictive accuracy of 90.9%, with 5 patients incorrectly
classified as failing (false negative), but no patients incorrectly classified as passing (false posi-
tive) (Table 6).
Discussion
The present study aimed to develop a method for the prediction of FTDr in patients with AD
which can be applied in a clinical setting, including clinical interviews, neuropsychological
assessment and driving simulator rides. The criterion FITtoDRIVE was the binary outcome of
an on-road driving assessment.
Patients with AD performed significantly worse than a healthy comparison group on the
clinical interviews, neuropsychological assessment and driving simulator rides reaching effect
sizes of up to 2.22 (Cohen’s d) (Table 2). Additionally, the percentage of patients with AD who
failed the on-road assessment (56.8%) was considerably larger than the percentage of healthy
participants who failed the on-road assessment (11.1%). Since the vast majority of healthy par-
ticipants passed the on-road assessment, age alone does not seem to indicate unsafe driving
[58,59]. The healthy comparison group was not included in further analyses, because the key
objective was to differentiate between fit and unfit drivers with AD.
Approximately half of the patients with AD passed the on-road assessment and the other
half failed, indicating that AD affects driving. Correspondingly, patients with AD were consis-
tently found to represent an at-risk group for unsafe driving in previous research [5,8–11].
Despite the association with unsafe driving, half of the patients with AD were evaluated as fit
to drive in the on-road assessment. The finding that some but not all patients with AD are
unfit to drive is in line with previous studies [9–11] and supports the need for the investigation
of FTDr in this population.
Within the group of patients with AD, patients who failed the on-road assessment per-
formed significantly worse than patients who passed the on-road assessment with regard to
clinical interviews, neuropsychological assessment and driving simulator rides reaching effect
sizes of up to 1.15 (Cohen’s d) (Table 3). The first goal was to determine which combination of
measures from each type of assessment is most predictive of failing the on-road assessment.
Clinical interviews were shown to be useful for the prediction of FITtoDRIVE with an overall
accuracy of 83.5% and 33.0% explained variance. Two sub-scores of the CDR, i.e. orientation
and judgement & problem solving, were shown to significantly predict FITtoDRIVE. Impair-
ments in orientation may lead to failure to perceive all relevant aspects of the infrastructure
and to an inability to follow routes [12]. Impairments in judgement could result in strategic
and tactical errors, such as driving in adverse weather conditions and overtaking in dangerous
circumstances. Although CDR subscorememory correlated with FITtoDRIVE in bivariate
analysis, the predictive accuracy of the logistic regression did not improve when entering this
variable to the model. The patient’s own judgement about driving safety and recent driving
experience were the two predictor variables that significantly contribute to the prediction
Table 6. Predictive accuracy of the final predictor variable with cut-off -0.6 (left) and -0.8 (right).
Prediction (-0.6) Fitness to drive Prediction (-0.8) Fitness to drive
Fail Pass Total Fail Pass Total
Fail 26 3 29 Fail 27 5 32
Pass 1 25 26 Pass 0 23 23
Total 27 28 55 Total 27 28 55
doi:10.1371/journal.pone.0149566.t006
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model. These two findings suggest that patients with mild AD may have meta-analytic skills
and are able to evaluate their own abilities and functioning, in contradiction to previous
research showing impaired awareness of their functioning in activities of daily living [60]. The
self-evaluation of driving abilities might have also affected recent driving experience, i.e.
patients who evaluate their own driving abilities as limited may reduce their driving experience
[61].
Neuropsychological test performance was also demonstrated to be predictive for FITtoD-
RIVE with an overall accuracy of 90.5% and 44.4% explained variance. One of the four predic-
tors was the MMSE, which supports the assumption that patients with a more severe dementia
are less likely to drive safely [14,15]. However, the MMSE alone has previously been found to
be insufficient for predicting FTDr [59]. Another predictor included in the model was a reac-
tion time measure of a selective auditory attention test. Slow reaction times of participants may
lead to too slow responses to traffic situations on the road as well. Two additional measures
were included in the model that do not come from classical neuropsychological tests, but from
tests specifically developed for the driving context, i.e. the correct trials of the hazard percep-
tion test and the response time in the traffic theory test. The knowledge about traffic rules and
recognition of hazards and selection of appropriate actions according to these hazards are
important aspects for safe driving so that it is not surprising that these measures contribute to
the prediction of FTDr. Further inspection of the predictors derived from the neuropsychologi-
cal assessment shows that the MMSE may be available from a routine clinical evaluation and
that simple reaction time tests are rather common in clinical neuropsychological assessments.
However, a hazard perception test and traffic theory test are tests specifically designed for the
assessment of FTDr. Dobbs and colleagues (2002) [21] have suggested that tests explicitly
designed for the prediction of FTDr may be much stronger predictors than classical neuropsy-
chological tests. The present results support this view only partially, since two predictors
originate from specialized traffic tests while two other predictors are derived from classical
neuropsychological tests. When looking at the odds ratios of the logistic regression analysis
from the neuropsychological assessment (Table 4), it appears that the hazard perception test
is very important for the prediction of FITtoDRIVE with 50.8% change in likelihood of FIT-
toDRIVE per one unit change. A substantially effect on FITtoDRIVE is also revealed for the
MMSE, with an odds ratio indicating a 31.9% increase in likelihood of FITtoDRIVE per one
unit change. This implicates that classical neuropsychological tests and specialized traffic tests
both can make an important contribution to the prediction of FTDr.
Driving simulator rides significantly predict FITtoDRIVE in patients with AD as well, with
an overall accuracy of 86.1% and 37.7% explained variance. Two predictor variables included
in the model were measured during the first intersections ride, the lowest speed when
approaching a specific intersection and the number of collisions. The other two predictor vari-
ables were measured during merging, i.e. the deceleration of the rear car after merging and the
time headway to the car in front after merging. These predictor variables indicate that patients
who drive fast towards an intersection where they have to give way, but drive slow when they
merge on the motorway right in front of another car, are likely to fail the on-road assessment.
These findings may indicate that patients who are unfit to drive do not anticipate for upcoming
traffic situations, since they do not make appropriate speed adjustments. The driving simulator
results also suggest that it is important for the prediction of FTDr to look at behaviour at inter-
sections where the participant has to give way and a merging manoeuvre besides measuring the
number of collisions, in particular as collisions are high impact events that should be avoided
in driving simulator research. Decreased lateral position control (SDLP) is frequently used for
studying the effects of alcohol and drugs on driving behaviour [62,63], but was not found to
predict FITtoDRIVE in patients with AD.
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The second goal of the present study was to compare the predictive value of the three types
of assessments. When comparing the accuracy of the prediction models on the same sample of
patients with AD (n = 55), neuropsychological assessment provided the best prediction of FIT-
toDRIVE (94.6% accuracy), followed by driving simulator rides (85.6% accuracy) and clinical
interviews (79.6% accuracy) (Fig 1). A clinical interview may not always be very informative,
because it requires meta-analytic skills and self-evaluation from the patient. Although results
presented above demonstrated these skills appear to be preserved at mild stages of AD, previ-
ous research showed that AD may affect these skills in the course of the disease [60]. Further-
more, it can be difficult to find an informant, which is crucial for a reliable prediction of FTDr
on the basis of clinical interviews. As a result, clinical interviews are less objective and less stan-
dardized than neuropsychological tests and driving simulator rides. Nevertheless, driving sim-
ulator rides were also not sufficiently predictive if used alone. Although driving simulator rides
share many characteristics with on-road driving (high face validity), it has also been stressed
that driving in a driving simulator is not the same as driving on the road [18,63]. Moreover,
driving simulators are originally not designed as a clinical tool while neuropsychological tests
are. This could explain why especially these tests are predictive for FTDr in patients with AD.
The third goal of the present study was to examine the best possible combination of the
three types of assessments. A combination of clinical interviews, neuropsychological assess-
ment and driving simulator rides presented the best prediction of FITtoDRIVE, yielding 97.4%
accuracy and 61.5% explained variance. Hence, a more thorough assessment provides a better
prediction model than the neuropsychological assessment only. When using all three types of
assessments and a cut-off of -0.6, the recommendation of Kay and colleagues (2012) [19] to
aim for both sensitivity and specificity of at least 90% is very close to being met (sensitivity
96.3%, specificity 89.3%). One could argue that all patients with AD who are unfit to drive
should always be classified correctly, because patients with AD who are unfit to drive will prob-
ably remain unfit to drive due to the progressive course of AD, resulting in a recommended
cut-off of -0.8. With cut-off -0.8, the sensitivity is 100% and the specificity is still high with
82.1%. Both cut-offs resulted in a classification accuracy above 90%. Previous studies already
suggested that using multiple tests may help in the prediction of FTDr [30]. The present results
suggest not only the use of multiple tests, but also the use of multiple types of assessments. The
three types of assessments appear to provide non-redundant and different types of information
that are all useful for the prediction of FTDr. The clinical interviews may provide information
about recent functioning of the patient in daily life, while a neuropsychological assessment
informs about specific cognitive abilities and driving simulator rides about operational and tac-
tical driving skills.
Limitations and future directions
Self-reports of patients with AD have limitations. A pitfall is asking patients with AD whether
they think they should cease driving, because patients who participate in an FTDr assessment
in general wish to continue driving. However, when asking whether they are driving less safely
than when they were middle-aged, they might admit that this is the case. In the present study,
both questions were asked. No patients answered that they think they should cease driving, but
their own judgement of driving safety was found to be predictive for FITtoDRIVE. Recent driv-
ing experience is another important predictor. It may be difficult for patients with AD to esti-
mate the kilometres driven in the preceding twelve months, but here informants may be able to
assist.
Simulator sickness is a common problem of older drivers [32,33]. In the current study,
countermeasures were used, i.e. simulator scenarios included no sharp turns and relatively few
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elements in the landscape, and the driving simulator had a high frame rate of 60 images per
second [64]. Nevertheless, simulator sickness occurred in approximately a third of the partici-
pants. Such high rates of simulator sickness have been found in older drivers before [32,33].
Simulator sickness is very inconvenient for the driver and might influence motivation and driv-
ing performance. For this reason, all participants who reported symptoms of simulator sickness
were excluded entirely from analyses involving driving simulator rides. Participants were not
invited to complete the driving simulator rides at another time in order to prevent another
experience with simulator sickness (ethical reason). Unfortunately, simulator sickness leads to
many missing data. The high rate of simulator sickness in older drivers limits the clinical utility
of the driving simulator for evaluations of older drivers. Moreover, a selection bias might
emerge as it remains unknown whether simulator sickness affects individuals randomly, or
whether it is associated with their ability to perform in the driving simulator. This might affect
a prediction model derived from the driving simulator data. Although Mullen and colleagues
(2010)[33] suggested that simulator sickness is not related to driving performance, patients
with simulator sickness who failed the on-road assessment are overrepresented in the current
study, i.e. 7 patients (29.2%) who suffered from simulator sickness passed the on-road assess-
ment while 17 patients (70.8%) with simulator sickness failed the on-road assessment. The fre-
quent occurrence of simulator sickness and the resulting selection bias are problems that have
to be dealt with when implementing driving simulator rides for the evaluation of older drivers
with AD in a clinical setting. Numerous attempts are being made to reduce the occurrence of
simulator sickness, e.g. by optical corrections, initial acclimation or olfactory cues [65–67],. If
these attempts will lead to a marked reduction in rates of simulator sickness, driving simulator
rides will become a promising method for investigating FTDr.
Although the classification accuracies are very high with both suggested cut-offs, there are
still several misclassifications which may lead to severe consequences for the individual and
other road users. Patients who are classified as unfit to drive while they are not (false negatives)
will be limited in independent mobility and autonomy for no reason [5,7]. Patients who are
classified as fit to drive while they are not (false positives) will continue to drive unsafely which
poses risks for both patients and public. As an explanation for false positives, it can be specu-
lated that patients with AD who pass tests and measures for FTDr might still be impaired at
on-road driving, as on-road driving requires the integration of several functions and abilities
under real life circumstances, and may thus represent a more complex process in comparison
to rather isolated tests and measures at the clinical assessment of FTDr. In future research, it
would be interesting to evaluate whether more complex assessment methods that require inte-
gration of functions and skills could predict such failure on the road [68,69]. As an explanation
of false negatives, it must be considered that patients with AD may be able to adapt to or com-
pensate for their cognitive impairment when driving on the road, e.g. by very careful driving
behaviour or much driving experience [59]. However, years of driving experience did not cor-
relate with FTDr in this study. Importantly, it is possible that patients with AD who are mis-
classified as unfit to drive might become unfit to drive soon after the assessment because of
their progressive disease, indicating that these patients with ADmay be advised to cease driving
just a little earlier than necessary. This hypothesis could be tested in longitudinal research. This
leads to the important and unanswered question whether the FTDr assessment could be per-
formed multiple times without being affected by re-test effects. A repeated assessment of FTDr
of patients with AD might be very beneficial considering the progressive course of AD, but also
because of additional medical conditions that may affect FTDr only temporarily (e.g. mild
stroke, bone fractures).
In order to reduce the number of misclassifications, one could choose not to dichotomize
the results into either fit or unfit, but to ‘trichotomize’ the results into three categories, i.e. fit,
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uncertain or unfit. In trichotomization, two cut-offs are used, meaning that patients scoring
below the low cut-off are regarded unfit to drive and patients scoring above the high cut-off are
regarded fit to drive, patients with a score in-between the two cut-offs are placed in an uncer-
tain group [70]. It is unclear whether patients in the uncertain group are fit to drive or not,
therefore the uncertain group requires further assessment on the road. For the patients in the
fit and unfit groups, the fitness-to-drive assessment method may replace the on-road driving
assessments in the future.
The on-road assessment was employed as the criterion as it is commonly used and it also
represents the current official relicensing procedure for patients with dementia in the Nether-
lands, however, it has several disadvantages. On-road assessments take place in a changing
environment, therefore different tasks will be encountered by different drivers even when driv-
ing the same route. In order to improve the comparability of the on-road assessments, a stan-
dardized and validated scoring form specifically designed for driving assessment of older
drivers was used, called the TRIP [11,54]. Nevertheless, even when using a standardized TRIP
form, many circumstances such as adverse weather conditions could impact on on-road assess-
ments. Notably, an on-road assessment is a single, short-term event which makes it vulnerable
for coincidental influences [13]. Moreover, patients may receive a doubtful outcome on the on-
road assessment if their driving performance is questionable. This outcome is insufficient to
renew a driving license, but these patients are invited to a second on-road assessment after tak-
ing driving lessons or applying car adaptations. It must be noted that the reliability of the on-
road assessment remains unknown what could be a threat to the implications drawn from the
present study. In order to investigate the reliability of the on-road assessment, it would be of
interest to have participants performing the on-road assessment several times to explore the
level of agreement between on-road assessments within subjects. Related to this, a follow-up
study would be helpful to determine whether the prediction in the current study corresponds
to driving behaviour in real-life situations, e.g. a naturalistic driving study.
A limitation inherent to the used analyses is the problem of capitalisation on chance [71].
Although the initial number of participants (81 patients with AD) is rather high for this type of
research [10,12,14,15], the number of participants with usable driving simulator data is smaller.
The large number of tests and measures may be problematic as predictors may be identified by
chance on the basis of the present sample, resulting in invalid conclusions for the population
of drivers with AD. Therefore, a replication of this study on an independent patient sample
would be desirable. The current study provides indications which variables differentiate well
between fit and unfit drivers with AD, but the method is not ready to be applied until the find-
ings are replicated in an independent patient sample.
For the current study, patients with AD were selected. Nonetheless, patients with other
aetiologies of dementia may be impaired in driving as well. The methodology applied in the
current study should therefore be employed in studies on FTDr on patients with other aetiolo-
gies than AD, e.g. vascular dementia, frontotemporal dementia and Parkinson’s dementia. This
is relevant as it was suggested recently that other predictor variables may play a role in the pre-
diction of FTDr in other aetiologies, because symptoms and prognoses of other aetiologies of
dementia differ from AD [13].
Conclusions
Measures from clinical interviews, neuropsychological assessment and driving simulator rides
were found to be predictive of on-road driving performance. When comparing the three types
of assessments, neuropsychological assessment provided the best prediction of FTDr followed
by driving simulator rides and clinical interviews. An even better prediction of FTDr was
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achieved when combining all three types of assessments. If the results can be replicated in an
independent sample of patients with AD, the developed method may be used to advise patients
with AD and their family members about FTDr.
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